Bal Pharma Limited Reports 2.7% Revenue Growth In Q4 FY26, Profit Falls 34%
Published on: May 27, 2026, 7:12 p.m. | Source: Free Press Journal
Bal Pharma Limited reported consolidated revenue of Rs 84.1 crore in Q4 FY26, up 2.7 percent year-on-year, while net profit declined 34 percent to Rs 3.6 crore. Sequentially, profit more than doubled from Q3 FY26 due to lower tax expenses and operational improvement in its pharmaceutical business operations.
